Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
01/2014
01/01/2014CN103479572A 1-[4-[3-amino-4-hydroxy-3-(hydroxymethyl)butyl]phenyl]-1-acetoxime hydrochloride microemulsion and preparation method thereof
01/01/2014CN102348459B Plasma-adapted full electrolyte solution
01/01/2014CN101679244B 5-membered heterocyclic derivative and use thereof for medical purposes
12/2013
12/31/2013US8618276 Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues
12/31/2013US8618174 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
12/31/2013US8618141 Aryl ureas with angiogenesis inhibiting activity
12/31/2013US8618086 Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
12/31/2013US8617587 Tasted masked veterinary solid compositions
12/31/2013US8617551 Methods of diagnosing pancreatic inflammation by using chemokine PANEC-1 antibodies
12/31/2013CA2543817C Fibroblast-mobilization agent containing a g-csf for repair of myocardial infarct lesion
12/31/2013CA2485847C Glucan-based vaccines
12/31/2013CA2467908C Mfg-e8-l regulates phagocytic removal of apoptotic cells by macrophages
12/27/2013WO2013191244A1 Pyridopyrimidin-4-one derivative
12/27/2013WO2013191187A1 Adhesive preparation composition obtained by blending drug, organic solvent, lipophilic ointment base, and powder
12/27/2013WO2013190978A1 Agent for inducing myeloid stem cells and method for inducing myeloid stem cells
12/27/2013CA2875454A1 Composition for patch preparation comprising drug, organic solvent, lipophilic mass base, and powder
12/26/2013US20130345409 Growth factor
12/26/2013US20130345265 Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient
12/26/2013US20130345238 Method of using diketopiperazines and composition containing them
12/26/2013US20130345180 2,4- diaminopyrimidine derivatives
12/26/2013US20130344166 Topical mixture and method for dermal application to remove excess iron and other heavy metals from cellular tissue
12/25/2013EP2676674A1 Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
12/25/2013EP2676670A1 Adiponectin production promoter, and medicinal composition, food, drink and feed containing adiponectin production promoter
12/25/2013EP2676664A1 Potentiator of antitumor activity of chemotherapeutic agent
12/25/2013EP2676662A1 Polymeric composition containing mineral fillers, for improving skin wound healing
12/25/2013EP2675433A1 Absorbent dressings with painkilling activity
12/25/2013EP2675276A1 PERIPHERIALLY ACTING µ OPIOID ANTAGONISTS
12/25/2013EP2498771B1 Use of bethanechol for treatment of xerostomia
12/25/2013EP2468729B1 Novel indazole derivative
12/25/2013EP2406248B1 Novel isoindolin-1-one derivative
12/25/2013EP2068871B1 Hydroxylated 1,2,4-oxadiazole benzoic acid compounds, compositions thereof and the use for nonsense suppression
12/25/2013CN103476421A Composition, glucose metabolism-improving agent, and method for improving glucose metabolism
12/25/2013CN103476412A Aclidinium for use in improving the quality of sleep in respiratory patients
12/25/2013CN103476399A Drug delivery particles and method for producing same
12/25/2013CN103463406A Traditional Chinese medicine for treating sweating sickness of disharmony of heart and kidney
12/25/2013CN103463146A Pharmaceutical composition for preventing birth defects and improving memory
12/25/2013CN103463101A Application of Kadcoccitones A in preparing monoamine oxidase (MAO) inhibitor
12/25/2013CN103463036A Application of Lycojaponicumin B in monoamine oxidase inhibitor medicine
12/25/2013CN102641268B Application of guanfu base A and guanfu base G
12/25/2013CN102174046B Tetomilast polymorphs
12/25/2013CN101835737B Spiro-ring compound and use thereof for medical purposes
12/24/2013US8614330 Substituted benz-azoles and methods of their use as inhibitors of RAF kinase
12/24/2013CA2641546C Therapeutic agent for inflammatory bowel disease containing as active ingredient 2-amino-1,3-propanediol derivative, or method for treating inflammatory bowel disease
12/24/2013CA2626134C Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
12/24/2013CA2397199C Nogo receptor-mediated blockade of axonal growth
12/24/2013CA2375104C Prevention and treatment of amyloidogenic disease
12/24/2013CA2349762C Human tslp dna and polypeptides
12/19/2013WO2013187533A1 Heteroarylcarboxylic acid ester derivative
12/19/2013WO2013187503A1 Glycine transporter inhibitor
12/19/2013WO2013187462A1 Piperidinylpyrazolopyridine derivative
12/19/2013WO2013187451A1 Patch
12/19/2013WO2013187391A1 COMPOSITION COMPRISING SESAMIN COMPOUND, γ-ORIZANOL AND RICE GERM OIL
12/19/2013WO2013187075A1 Prophylactic and/or therapeutic agent for mild cognitive impairment
12/19/2013WO2013187069A1 Pdt effect enhancing agent
12/19/2013WO2013185353A1 Compound as wnt signaling inhibitor, composition, and use thereof
12/19/2013WO2013152120A3 Compositions and methods for promoting intestinal stem cell function
12/19/2013US20130338071 GLP-1 Agonist and Cardiovascular Complications
12/19/2013US20130337549 Materials and methods for nerve grafting
12/19/2013CA2876573A1 Heteroarylcarboxylic acid ester derivative
12/19/2013CA2876382A1 Piperidinylpyrazolopyridine derivative
12/19/2013CA2876371A1 Prophylactic and/or therapeutic agent for mild cognitive impairment
12/19/2013CA2875372A1 Compound as wnt signaling inhibitor, composition, and use thereof
12/18/2013EP2344528B1 Pharmaceutical being used for treating cancer and fibrosis disease and the composition and uses thereof
12/18/2013EP2203061B1 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
12/18/2013EP2174666B1 Medicinal agent for treatment of amyloid beta-induced cerebral circulation or cerebral blood flow disorders
12/18/2013EP2165715B1 Therapeutic agent for cancer, and method for treatment of cancer
12/18/2013EP2098517B1 Novel phenyl-isoxazol-3-ol derivative
12/18/2013EP1932541B1 Apoptosis promoter, cell proliferation inhibitor, prophylactic/therapeutic agent for cancer, screening method for the promoter, inhibitor or agent
12/18/2013EP1782800B1 Methods for detecting JAK3 inhibitors
12/18/2013EP1656952B1 Polyalkylene glycol conjugates of interferon beta-1A and uses thereof
12/18/2013CN103459400A Novel imidazo-oxazine compound or salt thereof
12/18/2013CN103459388A Novel furanone derivative
12/18/2013CN103459380A Novel phenylpyridine derivative and drug containing same
12/18/2013CN103459379A Glycine transport inhibitor
12/18/2013CN103459369A 胍化合物 Guanidine compound
12/18/2013CN103450360A Antibodies to cd40
12/18/2013CN103446491A Drug for treating behcets disease
12/18/2013CN103446436A Pharmaceutical composition for preventing birth defects and improving memory
12/18/2013CN103446430A Pharmaceutical composition for preventing birth defects and improving memory
12/18/2013CN103446340A Pharmaceutical composition for preventing birth defects and improving memory
12/18/2013CN103446321A Traditional Chinese medicine composition for treating facial cyanoderma
12/18/2013CN103446299A Traditional Chinese medicine for treating thyroid cyst
12/18/2013CN103446269A Pharmaceutical composition for preventing birth defects and improving memory
12/18/2013CN103446252A Pharmaceutical composition for preventing birth defects and improving memory
12/18/2013CN103446251A Pharmaceutical composition for preventing birth defects and improving memory
12/18/2013CN103446225A Pharmaceutical composition for preventing birth defects and improving memory
12/18/2013CN103446219A Pharmaceutical composition for preventing birth defects and improving memory
12/18/2013CN103446216A Pharmaceutical composition for preventing birth defects and improving memory
12/18/2013CN103446210A Pharmaceutical composition for preventing birth defects and improving memory
12/18/2013CN103446200A Pharmaceutical composition for preventing birth defects and improving memory
12/18/2013CN103446199A Medicine for treating infantile hernia
12/18/2013CN102088978B Ameliorating or therapeutic agent for dyslipidemia
12/17/2013US8609656 Heteroarylphenylurea derivative
12/17/2013CA2782498C Tablet composition containing kampo medicinal extract and its manufacturing process
12/17/2013CA2668068C Combination therapy of substituted oxazolidinones
12/17/2013CA2637388C Pyrrolopyridazinone compound
12/17/2013CA2597273C Proteasome inhibitors and methods of using the same
12/17/2013CA2504401C Drug delivery systems for the prevention of neointimal hyperlasia
12/17/2013CA2496789C Methods for preserving organs and tissues
12/17/2013CA2427310C Imaging, diagnosis and treatment of angiogenesis-related diseases comprising ecsm4
1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ... 1564